Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01019902 · ClinicalTrials.gov registry record
Impact of Maternal Iron Status on Neonatal Iron Status and Auditory Brainstem Response in the Newborn
A clinical trial, sponsored by Cornell University.
- Completed
- Registry status
- 144
- Enrollment target
NCT01019902: Completed study, sponsored by Cornell University.
NCT01019902 is a clinical trial that has completed, run by Cornell University. The registered enrollment target is 144 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01019902 has completed, sponsored by Cornell University.
- COMPLETED
- Registry status
- 144 participants
- Enrollment target
Study Summary
This study aims to determine how maternal Fe status influences placental and neonatal Fe status in pregnant adolescents and to assess the impact of the Fe endowment of birth on functional outcomes as assessed by auditory brainstem responses within 48 h of delivery in neonates born to these adolescents.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2008-10 |
| Est. Completion | 2013-10 |
What the finished NCT01019902 record still lists
NCT01019902 is an observational study that tracks outcomes without assigning an intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01019902 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01019902 about?
NCT01019902 is a clinical study titled "Impact of Maternal Iron Status on Neonatal Iron Status and Auditory Brainstem Response in the Newborn". This study aims to determine how maternal Fe status influences placental and neonatal Fe status in pregnant adolescents and to assess the impact of the Fe endowment of birth on functional outcomes as assessed by auditory brainstem responses within 48 h of delivery in neonates born to these adolescen...
What is the current status of trial NCT01019902?
This trial is currently completed. The enrollment target is 144 participants. The study started on 2008-10. Estimated completion is 2013-10.
Who is sponsoring clinical trial NCT01019902?
This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia